{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-114695","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2026-10-08T20:05:15+00:00","discovered_at":"2026-10-08T20:06:00.592331+00:00","generated_at":"2026-10-12T15:30:07.072230+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"TELA Bio holders approve 1-for-5 to 1-for-15 reverse split; no split planned after Nasdaq compliance regained","bullets":["Special Meeting held October 8, 2026; 45,143,410 common shares outstanding as of the September 8, 2026 record date.","Proposal 1 approved: 30,515,571 votes for, 80,512 against, 1,737,011 abstentions, 0 broker non-votes.","Amendment would combine shares at a ratio of not less than one-for-five and not more than one-for-fifteen, exact ratio set by the Board in its sole discretion.","Proposal 2 (adjournment if needed) approved: 30,757,679 for, 123,860 against, 1,451,555 abstentions.","October 5, 2026 Nasdaq letter stated the company regained compliance with Listing Rule 5450(a)(1) minimum bid price; TELA Bio does not intend to effect the reverse split at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-114695","json":"https://secwatch.observer/filing/0001104659-26-114695.json","markdown":"https://secwatch.observer/filing/0001104659-26-114695.md","text":"https://secwatch.observer/filing/0001104659-26-114695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926114695/0001104659-26-114695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926114695/tm2627202d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:30:07.072230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}